Cefmenoxime hydrochloride

盐酸头孢甲肟

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameCefmenoxime hydrochloride
Drug Alias Name头孢甲肟盐酸盐cefmenoxima氨噻肟唑头孢菌素cefmenoximum头孢甲污 +[13] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1987/12/30
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co Ltd
Inactive CompaniesTap Pharmaceuticals Inc
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01DD05
Related LinksWikipediaDrugBankKEGG